Evofem Biosciences Total Assets 2013-2021 | EVFM
Evofem Biosciences total assets from 2013 to 2021. Total assets can be defined as the sum of all assets on a company's balance sheet.
Evofem Biosciences Annual Total Assets
(Millions of US $) |
| 2020 |
$110 |
| 2019 |
$28 |
| 2018 |
$4 |
| 2017 |
$4 |
| 2016 |
$13 |
| 2015 |
$40 |
| 2014 |
$77 |
| 2013 |
$5 |
| 2012 |
$13 |
Evofem Biosciences Quarterly Total Assets
(Millions of US $) |
| 2021-09-30 |
$67 |
| 2021-06-30 |
$109 |
| 2021-03-31 |
$93 |
| 2020-12-31 |
$110 |
| 2020-09-30 |
$112 |
| 2020-06-30 |
$135 |
| 2020-03-31 |
$16 |
| 2019-12-31 |
$28 |
| 2019-09-30 |
$39 |
| 2019-06-30 |
$54 |
| 2019-03-31 |
$3 |
| 2018-12-31 |
$4 |
| 2018-09-30 |
$15 |
| 2018-06-30 |
$26 |
| 2018-03-31 |
$9 |
| 2017-12-31 |
$4 |
| 2017-09-30 |
$6 |
| 2017-06-30 |
$8 |
| 2017-03-31 |
$11 |
| 2016-12-31 |
$13 |
| 2016-09-30 |
$15 |
| 2016-06-30 |
$23 |
| 2016-03-31 |
$26 |
| 2015-12-31 |
$40 |
| 2015-09-30 |
$53 |
| 2015-06-30 |
$64 |
| 2015-03-31 |
$72 |
| 2014-12-31 |
$77 |
| 2014-09-30 |
$0 |
| 2014-06-30 |
$0 |
| 2014-03-31 |
$0 |
| 2013-12-31 |
$5 |
| 2012-12-31 |
$13 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.067B |
$0.000B |
|
Evofem Biosciences Inc. develops and anticipates commercializing products which support and promote women as the primary healthcare consumer. The company is identifying and developing new and novel products which specifically address unmet needs in the areas of sexual and reproductive health, the prevention of acquisition of sexually transmitted infections and products which address or promote general health and wellbeing. Evofem Biosciences Inc., formerly known as Neothetics Inc., is based in SAN DIEGO CA.
|
